212 related articles for article (PubMed ID: 18060953)
1. Pelvic floor symptom changes in pessary users.
Komesu YM; Rogers RG; Rode MA; Craig EC; Gallegos KA; Montoya AR; Swartz CD
Am J Obstet Gynecol; 2007 Dec; 197(6):620.e1-6. PubMed ID: 18060953
[TBL] [Abstract][Full Text] [Related]
2. Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women undergoing vaginal surgery and pessary treatment for pelvic organ prolapse.
Barber MD; Walters MD; Cundiff GW;
Am J Obstet Gynecol; 2006 May; 194(5):1492-8. PubMed ID: 16647933
[TBL] [Abstract][Full Text] [Related]
3. Depressive symptoms affect outcomes of pessary use in postmenopausal women with uterine prolapse.
Ai FF; Zhu L; Mao M; Zhang Y; Kang J
Climacteric; 2018 Apr; 21(2):184-188. PubMed ID: 29397780
[TBL] [Abstract][Full Text] [Related]
4. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse.
Mao M; Ai F; Kang J; Zhang Y; Liang S; Zhou Y; Zhu L
Menopause; 2019 Feb; 26(2):145-151. PubMed ID: 30130292
[TBL] [Abstract][Full Text] [Related]
5. Pessary use in advanced pelvic organ prolapse.
Powers K; Lazarou G; Wang A; LaCombe J; Bensinger G; Greston WM; Mikhail MS
Int Urogynecol J Pelvic Floor Dysfunct; 2006 Feb; 17(2):160-4. PubMed ID: 15883856
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in women who use pessaries for longer than 12 months.
Tenfelde S; Tell D; Thomas TN; Kenton K
Female Pelvic Med Reconstr Surg; 2015; 21(3):146-9. PubMed ID: 25521465
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study on silicone pessary in the treatment of pelvic organ prolapse].
Yang JF; Han JS; Zhu FL; Wang YT; Yao Y; Qiao J
Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):487-91. PubMed ID: 23141156
[TBL] [Abstract][Full Text] [Related]
8. Changes in the symptoms and quality of life of women with symptomatic pelvic organ prolapse fitted with a ring with support pessary.
Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
Maturitas; 2018 Nov; 117():51-56. PubMed ID: 30314561
[TBL] [Abstract][Full Text] [Related]
9. Continence pessaries in the management of urinary incontinence in women.
Farrell SA; Singh B; Aldakhil L
J Obstet Gynaecol Can; 2004 Feb; 26(2):113-7. PubMed ID: 14965476
[TBL] [Abstract][Full Text] [Related]
10. Vaginal pessaries in managing women with pelvic organ prolapse and urinary incontinence: patient characteristics and factors contributing to success.
Hanson LA; Schulz JA; Flood CG; Cooley B; Tam F
Int Urogynecol J Pelvic Floor Dysfunct; 2006 Feb; 17(2):155-9. PubMed ID: 16044204
[TBL] [Abstract][Full Text] [Related]
11. Sexual activity predicts continued pessary use.
Brincat C; Kenton K; Pat Fitzgerald M; Brubaker L
Am J Obstet Gynecol; 2004 Jul; 191(1):198-200. PubMed ID: 15295365
[TBL] [Abstract][Full Text] [Related]
12. Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse.
Fernando RJ; Thakar R; Sultan AH; Shah SM; Jones PW
Obstet Gynecol; 2006 Jul; 108(1):93-9. PubMed ID: 16816061
[TBL] [Abstract][Full Text] [Related]
13. Effect of pessary use on genital hiatus measurements in women with pelvic organ prolapse.
Jones K; Yang L; Lowder JL; Meyn L; Ellison R; Zyczynski HM; Moalli P; Lee T
Obstet Gynecol; 2008 Sep; 112(3):630-6. PubMed ID: 18757662
[TBL] [Abstract][Full Text] [Related]
14. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse.
Clemons JL; Aguilar VC; Tillinghast TA; Jackson ND; Myers DL
Am J Obstet Gynecol; 2004 Apr; 190(4):1025-9. PubMed ID: 15118635
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported goal attainment and comprehensive functioning outcomes after surgery compared with pessary for pelvic organ prolapse.
Sung VW; Wohlrab KJ; Madsen A; Raker C
Am J Obstet Gynecol; 2016 Nov; 215(5):659.e1-659.e7. PubMed ID: 27319365
[TBL] [Abstract][Full Text] [Related]
16. The usage of Gellhorn pessary in pelvic organ prolapse and in regards to success, continuity of use and effect on symptoms: a retrospective study of 2 years.
Ramanujam S; Balakrishnan S
Med J Malaysia; 2023 Nov; 78(6):705-710. PubMed ID: 38031210
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of a novel, collapsible pessary for management of pelvic organ prolapse.
Strohbehn K; Wadensweiler PM; Richter HE; Grimes CL; Rardin CR; Rosenblatt PL; Toglia MR; Siddiqui G; Hanissian P
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38761837
[TBL] [Abstract][Full Text] [Related]
18. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial.
Cheung RY; Lee JH; Lee LL; Chung TK; Chan SS
Obstet Gynecol; 2016 Jul; 128(1):73-80. PubMed ID: 27275798
[TBL] [Abstract][Full Text] [Related]
19. Effect of generalized anxiety disorders on the success of pessary treatment for pelvic organ prolapse.
Ai FF; Mao M; Zhang Y; Kang J; Zhu L
Int Urogynecol J; 2018 Aug; 29(8):1147-1153. PubMed ID: 29478112
[TBL] [Abstract][Full Text] [Related]
20. What Are the Clinical Factors That Are Predictive of Persistent Pessary Use at 12 Months?
Chan MC; Hyakutake M; Yaskina M; Schulz JA
J Obstet Gynaecol Can; 2019 Sep; 41(9):1276-1281. PubMed ID: 30712905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
